(Q37321038)

19 August 2017

1 reference

title

Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy (English)

1 reference

19 August 2017

surgical intervention

1 reference

Paul Russo

1

1 reference

PubMed ID

18992621

19 August 2017

Matthew Francis O'Brien

series ordinal

2

1 reference

19 August 2017

1 November 2008

1 reference

Urologic Clinics of North America

19 August 2017

1 reference

19 August 2017

35

1 reference

19 August 2017

679-86; viii

1 reference

19 August 2017

4

1 reference

19 August 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Sunitinib therapy in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Renal cell carcinoma: survival and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Prognostic factors in metastatic renal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Renal cell carcinoma: resection of solitary and multiple metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Resection of metastatic renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Surgical resection of brain metastases from renal cell carcinoma in 50 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Surgery following response to interferon-alpha-based therapy for residual renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Cytoreductive nephrectomy: is it a realistic option in patients with renal cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Mode of presentation of renal cell carcinoma provides prognostic information

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

Metastatic Renal Cell Cancer and Radical Nephrectomy: Identification of Prognostic Factors and Patient Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UCL.2008.07.009

1 reference

19 August 2017

1 reference

PubMed ID

18992621